Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Sanofi crawled time : 21:00 save search
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
Published: 2024-03-14 (Crawled : 21:00) - globenewswire.com
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
CTSO | $0.8085 -6.73% -7.21% 150K
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: -8.33%
year results
IPG Tops the 2024 Ad Age 'A-List'
Published: 2024-03-11 (Crawled : 21:00) - globenewswire.com
IPG | $30.35 -0.23% 0.0% 2.5M
|
Commercial Services
|
| O: 0.15%
H: 1.59%
C: -1.36%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
MacroGenics Provides Update on Corporate Progress and 2023 Financial Results
Published: 2024-03-07 (Crawled : 21:00) - globenewswire.com
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
MGNX 4 | $16.67 -1.59% -1.62% 630K
|
Health Technology
|
| O: -5.7%
H: 11.12%
C: -9.88%
update financial results
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-07 (Crawled : 21:00) - globenewswire.com
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
IGMS | $9.28 -1.38% -1.4% 140K
|
Health Technology
|
| O: 2.14%
H: 9.69%
C: 0.97%
year update financial results
Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress
Published: 2024-02-26 (Crawled : 21:00) - globenewswire.com
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
RVMD S | $36.29 2.11% 2.07% 1.2M
|
Health Technology
|
| O: 4.15%
H: 2.04%
C: -3.22%
year update financial results
FDA Decisions: CMC Issues Thwart Venatorx and Melinta’s Urinary Tract Infecti...
Published: 2024-02-23 (Crawled : 21:00) - biospace.com/
PRGO A | $29.96 -0.56% 0.0% 1.4M
|
Health Technology
|
| O: 0.22%
H: 0.85%
C: 0.85%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.97%
H: 0.0%
C: 0.0%
fda
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides a Corporate Update
Published: 2024-02-15 (Crawled : 21:00) - globenewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: -1.59%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
NRIX 2 d | $14.67 -5.11% -5.39% 1.3M
|
Health Technology
|
| O: -6.09%
H: 9.95%
C: 6.7%
year update therapeutics financial results
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
Published: 2024-02-06 (Crawled : 21:00) - prnewswire.com
BMY | $48.26 -0.52% 0.04% 12M
|
Health Technology
|
| O: -0.14%
H: 0.35%
C: -1.12%
XNCR | $18.94 -5.82% -6.18% 500K
|
Health Technology
|
| O: -0.05%
H: 0.0%
C: -2.09%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
BGNE S | $134.08 -3.12% -3.22% 310K
|
Health Technology
|
| O: -3.53%
H: 1.53%
C: -0.27%
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: -6.22%
year financial results
Sanofi: Information concerning the total number of voting rights and shares - November 2023
Published: 2023-12-18 (Crawled : 21:00) - globenewswire.com
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: 0.0%
total
Press Release: Statement on FTC challenge to proposed license agreement with Maze Therapeutics
Published: 2023-12-11 (Crawled : 21:00) - globenewswire.com
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
license therapeutics agreement
IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension
Published: 2023-12-05 (Crawled : 21:00) - globenewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -2.77%
H: 0.49%
C: 0.49%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
IGMS | $9.28 -1.38% -1.4% 140K
|
Health Technology
|
| O: 1.56%
H: 4.75%
C: -0.77%
pipeline extension
IGM Biosciences Announces Third Quarter 2023 Financial Results
Published: 2023-11-13 (Crawled : 21:00) - globenewswire.com
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
IGMS | $9.28 -1.38% -1.4% 140K
|
Health Technology
|
| O: 7.96%
H: 6.43%
C: -3.59%
financial results
Panbela Provides Business Update and Reports Q3 2023 Financial Results
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -1.28%
H: 0.0%
C: 0.0%
PBLA | $0.54 -6.31% 79K
|
Professional, Scientific, and T...
|
| O: 6.53%
H: 0.0%
C: -3.63%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
business update financial results
Denali Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
Published: 2023-11-07 (Crawled : 21:00) - globenewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
DNLI | $17.35 -2.75% -2.82% 1.1M
|
Health Technology
|
| O: -5.61%
H: 4.24%
C: 0.7%
business therapeutics financial results
OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC Study
Published: 2023-11-06 (Crawled : 21:00) - prnewswire.com
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
TXG | $30.81 -6.24% -6.65% 2.2M
|
Health Technology
|
| O: -0.98%
H: 3.21%
C: 1.96%
genomics study
Merck’s Keytruda and Novartis’ Cosentyx Earn New FDA Nods
Published: 2023-11-02 (Crawled : 21:00) - biospace.com/
PRGO A | $29.96 -0.56% 0.0% 1.4M
|
Health Technology
|
| O: 0.46%
H: 1.28%
C: -1.17%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: 0.08%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 3.0%
H: 0.0%
C: 0.0%
fda cosentyx keytruda
Spinal Cord Injury Market Likely to Exhibit Substantial Growth by 2032, Assesses DelveInsight | Companies to Watch Out - NervGen Pharma, StemCyte, Mitsubishi Tanabe Pharma America, AbbVie
Published: 2023-11-01 (Crawled : 21:00) - prnewswire.com
TGTX | $14.02 -0.36% -0.36% 1.6M
|
Health Technology
|
| O: 0.0%
H: 11.07%
C: 2.87%
SUPN | $29.39 -2.0% -2.04% 390K
|
Health Technology
|
| O: 1.38%
H: 1.49%
C: -0.7%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 3.0%
H: 0.0%
C: 0.0%
GERN | $3.6 4.35% 4.17% 6.4M
|
Health Technology
|
| O: 0.0%
H: 4.15%
C: -7.77%
pharma companies abbvie growth market
Primary Sclerosing Cholangitis Market to Grow at a Tremendous CAGR of 17.2% During the Study Period (2019-2032) | DelveInsight
Published: 2023-10-31 (Crawled : 21:00) - prnewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 0.94%
H: 2.55%
C: 2.55%
ALPMY | $9.2715 -1.11% 500K
|
Manufacturing
|
| O: -4.18%
H: 0.49%
C: -0.02%
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -2.76%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
PLRX | $13.24 -2.29% -2.34% 430K
|
Health Technology
|
| O: -0.2%
H: 3.45%
C: 1.37%
CALT | $18.95 -6.37% 9.4K
|
Health Technology
|
| O: -2.27%
H: 2.01%
C: 0.44%
study market
Generalized Anxiety Disorder Treatment Market to Showcase Positive Growth During the Forecast Period (2023-2032), Assesses DelveInsight | Key Players - MindMed, VistaGen Therapeutics, Actavis, Takeda Pharmaceuticals, Bionomics
Published: 2023-10-30 (Crawled : 21:00) - prnewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 4.66%
H: 0.0%
C: -3.51%
ALPMY | $9.2715 -1.11% 500K
|
Manufacturing
|
| O: -1.67%
H: 3.16%
C: 2.75%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 2.61%
H: 0.0%
C: 0.0%
positive treatment growth market
Tricks and Treats as Biopharma’s Q3 Earnings Season Gets Underway
Published: 2023-10-27 (Crawled : 21:00) - biospace.com/
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -18.18%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -15.73%
H: 0.0%
C: 0.0%
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.